Skip to main content
. 2024 Jul 2;17(8):sfae200. doi: 10.1093/ckj/sfae200

Figure 2:

Figure 2:

(a) usPD-1 concentration in cancer patients. (b) ROC curve to differentiate ATN from AIN in the subset of cancer patients. (c) Statistics and optimum cutoff values of biomarkers. PLR, positive likelihood ratio.